Consolidated Portfolio Review Corp’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,977
Closed -$1.26M 197
2025
Q3
$1.26M Buy
51,977
+3,083
+6% +$74.7K 0.16% 143
2025
Q2
$1.19M Buy
48,894
+3,624
+8% +$87.5K 0.16% 139
2025
Q1
$1.1M Buy
45,270
+4,042
+10% +$97.5K 0.18% 131
2024
Q4
$992K Buy
41,228
+3,309
+9% +$79.8K 0.16% 151
2024
Q3
$921K Buy
37,919
+1,487
+4% +$35.8K 0.21% 124
2024
Q2
$868K Buy
36,432
+3,112
+9% +$73.9K 0.2% 128
2024
Q1
$795K Buy
33,320
+1,635
+5% +$39K 0.21% 119
2023
Q4
$757K Buy
31,685
+1,503
+5% +$35.3K 0.17% 134
2023
Q3
$704K Buy
30,182
+363
+1% +$8.5K 0.17% 138
2023
Q2
$700K Buy
29,819
+291
+1% +$6.88K 0.17% 138
2023
Q1
$701K Buy
+29,528
New +$695K 0.19% 126

Other funds holding IBDR

Consolidated Portfolio Review Corp's IBDR Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of iShares iBonds Dec 2026 Term Corporate ETF (IBDR) in Q4 2025, closing a stake of 51,977 shares — an estimated $1.26M sold.

Consolidated Portfolio Review Corp first reported a position in IBDR in Q1 2023 and held it in 11 quarters. The position peaked at $1.26M in Q3 2025. 436 funds tracked by Wall St. Rank hold IBDR as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining iShares iBonds Dec 2026 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 51,977 iShares iBonds Dec 2026 Term Corporate ETF shares in Q4 2025, an estimated $1.26M.
  • Consolidated Portfolio Review Corp first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2023 and held it in 11 quarters.
  • Consolidated Portfolio Review Corp's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $1.26M in Q3 2025.
  • 436 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.